No Detail Found!

The prevalence of adverse drug event‑related admissions at a local hospital in M alaysia

Author(s)
Mahmathi Karuppannan Department of Pharmacy Practice, Faculty of Pharmacy, Puncak Alam Campus, UiTM
Ting Kang Nee School of Biomedical Sciences, University of Nottingham Malaysia Campus,
Salmiah Mohd Ali School of Pharmacy, Taylor’s University, Malaysia,
Wong Kok Thong School of Pharmacy, University of Nottingham Malaysia Campus
Helen Boardman School of Pharmacy, University of Nottingham, United Kingdom
Abstract
Aims: To determine the prevalence of adverse drug event (ADE)-related admissions and the related drugs. Setting and Designs: This study was conducted prospectively in two medical wards in Malaysia. Subjects and Methods: Information was collected from patients’ medical and medication charts over a period of 24 weeks. All screened patients were assessed using a list of criteria and were classified into: Therapeutic failure (TF), adverse drug reaction (ADR), medication error (ME), and drug overdose (DO). Patients admitted due to ADEs and its subcategories were analyzed and presented in counts and percentages. The prevalence of ADE-related admissions and the drug associated with each category were identified and calculated. Results: Out of 1,200 screened patients, 39% (n = 443) were ADE-related admissions. A total of 483 ADEs were identified; 79% (n = 351) were due to TF, 21% (n = 94) were due to ADR, 5% (n = 21) were due to DO, and 3% (n = 15) were due to ME. Cardiovascular drugs, antidiabetics, and antiasthmatics were most commonly associated with these admissions. The most common complaint by patients admitted due to a TF was chest pain, whilst hypoglycemia was the main cause of admission related to ADRs. Conclusions: The prevalence of admissions related to ADEs is high in Malaysia and this was mainly contributed by admissions related to TF. Some useful strategies such as educational interventions on the main causes of ADEs, monitoring of patients prescribed with drugs most commonly associated with ADEs, and appropriate prescribing should be targeted at all healthcare professionals to prevent future occurrences. However, further investigation is needed to clarify the high proportion of patients admitted due to TF
Publication Details
Page(s) 160-167
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 4, Issue: 4, Year: 2013

Request the full text from PASTIC

Keywords
Adverse drug events adverse drug reactions, prevalence therapeutic failure
References
Safety . .The Uppsala Monitoring Centre, WHO collaborating Centre for International Drug Monitoring; c2000. org/graphics/24747.pdf [Last cited on 2013 May, 25 : .
Runciman WB,Roughead EE,Semple SJ,Adams RJ .2003 .Adverse drug events and medication errors in Australia. Int J Qual Health Care, 15(Suppl 1) : i49-59.
Jha AK,Kuperman GJ,Rittenberg E,Bates DW .2001 .Identifying hospital admissions due to adverse drug events using a computer‑based monitor. Pharmacoepidemiol Drug Saf, 10 : 113-9.
Zargarzadeh AH,Emami MH,Hosseini F .2007 .Drug‑related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol, 34 : 494-8.
Howard RL,Aver y AJ,Howard PD,Partridge M. .2003 .Investigation into the reasons for preventable drug related admissions to a medical admissions unit: Observational study. Qual Saf Health Care, 12 : 2805.
Nelson KM,Talbert RL .1996 .Drugr‑elated hospital admissions. Pharmacother, 16 : 701-7.
Elixhauser A,Owens P. .2004 .Agency for Healthcare Research. [Last cited on 2013 May, 5 : 29.
Schneeweiss S,Hasford J,Göttler M,Hoffmann A,Riethling AK,Avorn J .2002 .Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: A longitudinal population‑based study. Eur J Clin Pharmacol, 58 : 285-91.
Saha L,Pandhi P,Malhotra S,Sharma N. Adverse,Drug N. Adverse .2008 .Event (ADE) related Medical Emergency Department visits and hospital admissions: A prospective study from a North Indian Referral Hospital. J Clin Diagn Res, 2 : 600-4.
Bhalla N,Duggan C,Dhillon S. .2003 .The incidence and nature of drug‑related admissions to hospital. Pharm J, 270 : 583-6.
Chan M,Nicklason F,Vial JH .2001 .Adverse drug events as a cause of hospital admission in the elderly. Intern Med J, 31 : 199-205.
Hallas J,Gram LF,Grodum E,Damsbo N,Brosen K,Haghfelt T .1992 .Drug related admissions to medical wards: A population based survey. Bri J Clin Pharmacol, 33 : 61-8.
Raschetti R,Morgutti M,Menniti‑Ippolito F,Belisari A,Rossignoli A,Longhini P .1999 .Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol, 54 : 959-63.
Bergman U,Wiholm BE .1981 .Drug‑related problems causing admission to a medical clinic. Eur J Clin Pharmacol, 20 : 193-200.
Syed A .2003 .. Drug Inf J, 37 : 143-8.
.2012 .. menuid=149 & parentid=17 [Last cited on 2013 Feb, 3 : c-2012.
. .. [Last cited on 2013 May, 5 : .
. .. Introduction [Last updated on 2013 July 3; Last cited on 2013 July, 20 : .
Farooqui M,Noorizan AA,Hassan Y,Azhar S,Ghazalli R .2005 .Drug related problems as a cause of admission to the medical wards of hospital Pulau Pinang. Malaysian J Pharm Sci, 3(26) : 65-6.
Loganadan NK,AbRahman NS,Mokhtar F NS .2005 .A study on the management of uncontrolled diabetes In: Medical Wards Of Hospital Kuala Lumpur. Malaysian J Pharm Sci, 3 : 43-114.
Naing L,Winn T,Rusli B .2006 .Practical issues in calculating the sample size for prevalence studies. Arch Orofacial Sci, 1 : 9-14.
Morimoto T,Gandhi TK,Seger AC,Hsieh TC,Bates DW .2004 .Adverse drug events and medication errors: Detection and classification methods. Qual Saf Health Care, 13 : 306-14.
Edwards IR,Aronson JK .2000 .Adverse drug reactions: Definitions, diagnosis, and management. Lancet, 356 : 1255-9.
Riedl MA,Casillas AM .2003 .Adverse drug reactions: Types and treatment options. Am Fam Physician, 68 : 1781-90.
. .‑mc. org/graphics/4409.pdf [Last cited on 2013 May, 25 : .
Hallas J,Harvald B,Gram LF,Grodum E,Brosen K,Haghfelt T .1990 .Drug‑related hospital admission: The role of definition and intensity of data collection and the possibility of prevention. J Intern Med, 228 : 83-90.
Naranjo CA,Busto U,Sellers EM,Sandor P,Ruiz I,Roberts EA .1981 .A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 30 : 239-45.
Camidge DR,Wood RJ,Bateman DN .2003 .The epidemiology of self‑poisoning in the UK. Bri J Clin Pharmacol, 56 : 613-9.
. .The NCC MERP Taxonomy of Medication Errors [Internet]. National Coordinating Council for Medication Error Reporting and Prevention; c1998. org/pdf/taxo20010‑73‑1.pdf [Last cited on 2013 May, 25 : .
Landis JR,Koch GG .1977 .The measurement of observer agreement for categorical data. Biometrics, 33 : 1597-4.
Schwake L,Wollenschläger I,Stremmel W,Encke J .2009 .Adverse drug reactions and deliberate self‑poisoning as cause of admission to the intensive care unit: A 1‑year prospective observational cohort study. Intensive Care Med, 35 : 266-74.
Leendertse AJ,Visser D,Egberts AC .2010 .The relationship between study characteristics and the prevalence of medication‑related hospitalisations: A literature review and novel analysis. Drug Saf, 33 : 233-44.
Hurwitz N. .1969 .Admissions to hospital due to drugs. Bri Med J, 1 : 539-40.
.1997 .Drug‑associated admissions to a district hospital in Saudi Arabia. J Clin Pharm Ther, 22 : 616.
Franceschi A,Tuccori M,Bocci G,Vannozzi F,Paola AD,Barbara C .2004 .Drug therapeutic failures in emergency department patients: A university hospital experience. Pharmacol Res, 49 : 85-91.
Malhotra S,Karan RS,Pandhi P,Sharma N. .2001 .Drug related medical emergencies in the elderly: Role of adverse drug reactions and non‑complianc e. Postgrad Med J, 77 : 703-7.
Davidsen F,Haghfelt T,Gram LF,Brosen K. .1988 .Adverse drug reactions and drug non‑compliance as primary causes of admission to a cardiology department. Eur J Clin Pharmacol, 34 : 83-6.
Zambahari R. .2004 .Trends in cardiovascular diseases and risk factors in Malaysia. Int Congr Ser, 1262 : 446-9.
. .. Last cited on 2013 Jan, 20 : .
Rampal L,Rampal S,Azhar MZ,Rahman AR .2008 .Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects. Public Health, 122 : 11-18.
Sim KH .2006 .National Cardiovascular Disease Database. org.my/ ncvd [Last cited on 2013 Feb, 2 : .
Letchuman GR,Wan Nazaimoon WM,Wan Mohamad WB,Chandran LR,Tee GH,Jamaiyah H .2010 .. Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia, 65 : 173-9.
Rampal S,Rampal L,Rahmat R,Zain AM,Yee GY,Mohamed M .2010 .Variation in the prevalence, awareness, and control of diabetes in a multiethnic population: A nationwide population study in Malaysia. Asia Pacific J Public Health, 22 : 194-202.
.2012 ._page_by_page. pdf [Last cited on 2013 May, 25 : .
Manaf NH .2012 .Inpatient satisfaction: An analysis of Malaysian public hospitals. Int J Public Sector Manag, 25 : 6-16.
Pillay DI,Ghazali RJ,Manaf NH,Abdullah AH,Bakar AA,Salikin F .2011 .Hospital waiting time: The forgotten premise of healthcare service delivery?. Int J Health Care Qual Assur, 24 : 506-22.
Manaf NH .2006 .Patient satisfaction in outpatient clinics of Malaysian public hospitals. IIUM J Econ Manag, 14 : 81-110.
Lim P,Lim K .2010 .Evaluation of a pharmacist‑managed diabetes medication therapy adherence clinic. Pharm Pract (Internet), 8 : 250-4.
Green CF,Mottram DR,Rowe PH,Pirmohamed M. .2000 .Adverse drug reactions as a cause of admission to an acute medical assessment unit: A pilot study. J Clin Pharm Ther, 25 : 355-61.
Sarojini S,Faridah A,Lim CM,Sameerah SA,Lim TO,Lai LS .2008 .Use of prescription medicines in Malaysia 2005. Med J Malaysia, 63 : 203-6.
Nee TK,Ali SM,Thong WK,Boardman H. .2013 .The prevalence of adverse drug eventr‑elated admissions at a local hospital in Malaysia. Arch Pharma Pract, 4 : 1607.
0

Citations

0

Downloads

15

Views